))
Can Hormonal Therapy Help Treat Triple-Negative Breast Cancer?
Manage episode 454214420 series 3482052
Contenido proporcionado por Breastcancer.org. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Breastcancer.org o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
New research suggests that estrogen plays a role in allowing hormone receptor-negative breast cancer to grow. This is because estrogen limits the ability of the immune system to attack cancer cells; it also makes immunotherapy medicines, like Keytruda (chemical name: pembrolizumab), less effective. Dr. Donald McDonnell, senior author of the study, explains the results and how they might make a difference for people with breast cancer.
Listen to the episode to hear Dr. McDonnell explain:
- what eosinophils are and how he started studying them in connection with breast cancer
- how estrogen in the body affects the immune system
- how a hormonal therapy medicine, like tamoxifen, can make an immunotherapy medicine, like Keytruda, more effective
323 episodios
Compartir
